RegRapPod: InConversation
RegRapPod: InConversation
Podcast Description
RegRapPod: InConversation is the podcast series of the TOPRA member's journal Regulatory Rapporteur. If you'd like to appear as a guest on the podcast, or otherwise contribute to the journal, please email [email protected].
Podcast Insights
Content Themes
The podcast explores themes surrounding regulatory affairs in the pharmaceutical industry, with episodes focusing on electronic product information (ePI), sustainability in pharmaceuticals, career paths into regulatory roles, and the challenges posed by Identification of Medicinal Products (IDMP) requirements.
RegRapPod: InConversation is the podcast series of the TOPRA member’s journal Regulatory Rapporteur.
If you’d like to appear as a guest on the podcast, or otherwise contribute to the journal, please email [email protected].
In this episode of RegRapPod – InConversation, host Claire McDermott talks with Zohra Nasir, Senior Manager Regulatory Affairs at Teva Pharmaceutials, and Aksa Rahman, Regulatory Affairs Project Manager at Grunenthal Ltd, about careers in regulatory affairs and, in particular, how you find your first role.
Aimed primarily at students, graduates and those who are considering a career in regulatory affairs, this podcast discusses how to identify roles that best suit you, how to gain experience and how to make your CV stand out from the crowd. It also discusses strategies that those in hiring positions in industry can adopt to help promote regulatory affairs as a career and how you can open doors for the next generation.
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.